Historical salary details - Ms. Ellen M. Zane, Chairman of the Board, Haemonetics Corp.
Ms. Ellen M. Zane is the Chairman of the Board of Haemonetics Corp.. They also hold 3 other positions in Boston Scientific Corp., Azenta Inc and Synchrony Financial.
Ms. Ellen M. Zane
Chairman of the Board
$ 869.2 K
Gross Remuneration
-
Current Company
Haemonetics Corp.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Haemonetics Corp. | Chairman of the Board | 450.0 K | 2.3 % |
| 2024 | Boston Scientific Corp. | Independent Director | 356.7 K | 6.5 % |
| 2024 | Azenta Inc | Independent Director | 62.5 K | -78.4 % |
| 2024 | Synchrony Financial | Independent Director | - | - |
| 2023 | Haemonetics Corp. | Chairman of the Board | 440.0 K | 17.5 % |
| 2023 | Boston Scientific Corp. | Independent Director | 335 K | 4.7 % |
| 2023 | Synchrony Financial | Independent Director | 300.1 K | 0.0 % |
| 2023 | Azenta Inc | Independent Director | 290.0 K | 2.6 % |
| 2022 | Haemonetics Corp. | Chairman of the Board | 374.3 K | 38.7 % |
| 2022 | Boston Scientific Corp. | Independent Director | 320 K | 0.0 % |
| 2022 | Synchrony Financial | Independent Director | 300.1 K | 11.5 % |
| 2022 | Azenta Inc | Independent Director | 282.6 K | 8.7 % |
| 2021 | Boston Scientific Corp. | Independent Director | 320 K | 22.3 % |
| 2021 | Haemonetics Corp. | Independent Director | 269.9 K | 3.8 % |
| 2021 | Synchrony Financial | Independent Director | 269.1 K | 11.2 % |
| 2021 | Azenta Inc | Independent Director | 260.1 K | 8.4 % |
| 2020 | Boston Scientific Corp. | Independent Director | 261.7 K | -12.8 % |
| 2020 | Haemonetics Corp. | Independent Director | 259.9 K | 4.0 % |
| 2020 | Synchrony Financial | Independent Director | 242.1 K | 16.3 % |
| 2020 | Azenta Inc | Independent Director | 240.0 K | 0.0 % |
| 2019 | Boston Scientific Corp. | Independent Director | 300.0 K | 1.7 % |
| 2019 | Haemonetics Corp. | Independent Director | 249.9 K | 148.9 % |
| 2019 | Azenta Inc | Independent Director | 240.0 K | 14.3 % |
| 2019 | Synchrony Financial | Independent Director | 208.2 K | - |
| 2018 | Boston Scientific Corp. | Independent Director | 295.0 K | 4.7 % |
| 2018 | Azenta Inc | Independent Director | 210.0 K | 3.7 % |
| 2018 | Haemonetics Corp. | Independent Director | 100.4 K | - |
| 2018 | Synchrony Financial | Independent Director | - | - |
| 2017 | Boston Scientific Corp. | Independent Director | 281.6 K | 8.6 % |
| 2017 | Azenta Inc | Independent Director | 202.5 K | 9.5 % |
| 2016 | Boston Scientific Corp. | Independent Director | 259.3 K | - |
| 2016 | Haemonetics Corp. | Independent Director | 245.0 K | 2.8 % |
| 2016 | Azenta Inc | Independent Director | 185.0 K | 5.7 % |
| 2015 | Haemonetics Corp. | Independent Director | 238.3 K | 17.8 % |
| 2015 | Azenta Inc | Independent Director | 175.0 K | 2.9 % |
| 2015 | Boston Scientific Corp. | Independent Director | - | - |
| 2014 | Haemonetics Corp. | Independent Director | 202.2 K | -15.3 % |
| 2014 | Azenta Inc | Independent Director | 170.0 K | 1.5 % |
| 2013 | Haemonetics Corp. | Independent Director | 238.9 K | - |
| 2013 | Azenta Inc | Independent Director | 167.5 K | 103.4 % |
| 2012 | Azenta Inc | Independent Director | 82.3 K | - |
| 2012 | Haemonetics Corp. | Independent Director | - | - |